| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caspase 8 | 9 | 2026 | 66 | 2.980 |
Why?
|
| Inflammasomes | 18 | 2023 | 348 | 2.780 |
Why?
|
| Inflammation | 17 | 2026 | 1186 | 1.950 |
Why?
|
| Immunity, Innate | 11 | 2020 | 819 | 1.900 |
Why?
|
| Plague | 7 | 2018 | 23 | 1.890 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 5 | 2026 | 84 | 1.630 |
Why?
|
| Cell Death | 8 | 2026 | 289 | 1.530 |
Why?
|
| Yersinia pestis | 8 | 2016 | 33 | 1.520 |
Why?
|
| Toll-Like Receptor 4 | 21 | 2023 | 350 | 1.480 |
Why?
|
| Adjuvants, Immunologic | 8 | 2015 | 235 | 1.290 |
Why?
|
| Macrophages | 16 | 2026 | 1035 | 1.280 |
Why?
|
| Signal Transduction | 38 | 2026 | 3143 | 1.280 |
Why?
|
| Pyroptosis | 3 | 2025 | 38 | 1.210 |
Why?
|
| Receptors, Cell Surface | 20 | 2005 | 431 | 1.190 |
Why?
|
| Membrane Glycoproteins | 19 | 2005 | 662 | 1.120 |
Why?
|
| Interleukin-1beta | 13 | 2026 | 272 | 1.090 |
Why?
|
| Carrier Proteins | 8 | 2018 | 718 | 1.070 |
Why?
|
| Mice | 61 | 2026 | 11088 | 1.000 |
Why?
|
| Animals | 79 | 2026 | 21292 | 0.990 |
Why?
|
| Myeloid Differentiation Factor 88 | 12 | 2014 | 203 | 0.950 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 2016 | 127 | 0.920 |
Why?
|
| Mice, Knockout | 27 | 2025 | 2152 | 0.890 |
Why?
|
| Lipid A | 6 | 2015 | 67 | 0.880 |
Why?
|
| Toll-Like Receptor 2 | 16 | 2014 | 219 | 0.860 |
Why?
|
| Interleukin-18 | 9 | 2020 | 75 | 0.860 |
Why?
|
| Toll-Like Receptors | 25 | 2020 | 434 | 0.850 |
Why?
|
| Lipopolysaccharides | 19 | 2020 | 623 | 0.810 |
Why?
|
| Yersinia Infections | 3 | 2025 | 10 | 0.810 |
Why?
|
| RNA Splicing | 1 | 2025 | 166 | 0.810 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 14 | 2023 | 261 | 0.810 |
Why?
|
| Mice, Inbred C57BL | 28 | 2025 | 3469 | 0.740 |
Why?
|
| Apoptosis Regulatory Proteins | 6 | 2018 | 152 | 0.740 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2019 | 345 | 0.730 |
Why?
|
| RNA-Binding Proteins | 2 | 2025 | 447 | 0.720 |
Why?
|
| Host-Pathogen Interactions | 3 | 2018 | 278 | 0.690 |
Why?
|
| Dendritic Cells | 10 | 2020 | 531 | 0.670 |
Why?
|
| Saponins | 3 | 2015 | 26 | 0.670 |
Why?
|
| AIDS Vaccines | 3 | 2015 | 72 | 0.620 |
Why?
|
| Bacterial Proteins | 5 | 2019 | 739 | 0.580 |
Why?
|
| Protein Kinases | 2 | 2023 | 153 | 0.580 |
Why?
|
| Sugars | 1 | 2018 | 5 | 0.570 |
Why?
|
| I-kappa B Kinase | 1 | 2018 | 50 | 0.570 |
Why?
|
| Lipopolysaccharide Receptors | 11 | 2020 | 144 | 0.560 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2018 | 36 | 0.560 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2018 | 83 | 0.550 |
Why?
|
| Virulence | 3 | 2016 | 199 | 0.530 |
Why?
|
| Bacterial Infections | 2 | 2023 | 150 | 0.520 |
Why?
|
| Bacterial Secretion Systems | 1 | 2016 | 11 | 0.500 |
Why?
|
| Pyrin | 1 | 2016 | 8 | 0.500 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 3 | 2014 | 81 | 0.500 |
Why?
|
| Cells, Cultured | 16 | 2019 | 2188 | 0.450 |
Why?
|
| Receptors, Interleukin | 1 | 2014 | 38 | 0.440 |
Why?
|
| Lymphocyte Antigen 96 | 6 | 2009 | 47 | 0.430 |
Why?
|
| Cytokines | 12 | 2023 | 951 | 0.410 |
Why?
|
| NF-kappa B | 9 | 2026 | 434 | 0.400 |
Why?
|
| Docosahexaenoic Acids | 1 | 2013 | 31 | 0.400 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2013 | 18 | 0.400 |
Why?
|
| Drosophila Proteins | 10 | 2003 | 758 | 0.380 |
Why?
|
| Virulence Factors | 2 | 2019 | 85 | 0.380 |
Why?
|
| Tumor Necrosis Factor-alpha | 10 | 2026 | 603 | 0.310 |
Why?
|
| Macrophages, Peritoneal | 6 | 2014 | 74 | 0.300 |
Why?
|
| Receptors, Immunologic | 5 | 2016 | 179 | 0.300 |
Why?
|
| Phosphate-Binding Proteins | 2 | 2019 | 20 | 0.290 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2018 | 206 | 0.290 |
Why?
|
| Gene Expression Regulation | 6 | 2020 | 1629 | 0.290 |
Why?
|
| Apoptosis | 6 | 2023 | 1100 | 0.290 |
Why?
|
| RNA, Double-Stranded | 3 | 2011 | 112 | 0.280 |
Why?
|
| Antigens, Differentiation | 4 | 2004 | 144 | 0.280 |
Why?
|
| Streptococcus agalactiae | 4 | 2014 | 81 | 0.280 |
Why?
|
| Humans | 51 | 2024 | 64954 | 0.270 |
Why?
|
| Toll-Like Receptor 3 | 4 | 2013 | 66 | 0.260 |
Why?
|
| Plague Vaccine | 1 | 2006 | 5 | 0.250 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2009 | 630 | 0.240 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 731 | 0.240 |
Why?
|
| Up-Regulation | 7 | 2015 | 373 | 0.240 |
Why?
|
| Caspase 1 | 6 | 2023 | 112 | 0.230 |
Why?
|
| Bone Marrow Cells | 3 | 2015 | 237 | 0.230 |
Why?
|
| Vaccines, DNA | 3 | 2014 | 98 | 0.220 |
Why?
|
| Disease Resistance | 1 | 2025 | 27 | 0.220 |
Why?
|
| HIV Envelope Protein gp120 | 3 | 2015 | 130 | 0.220 |
Why?
|
| Interferon-beta | 3 | 2014 | 79 | 0.210 |
Why?
|
| Gram-Negative Bacteria | 2 | 2018 | 56 | 0.210 |
Why?
|
| Interferons | 1 | 2024 | 74 | 0.210 |
Why?
|
| Microglia | 3 | 2021 | 250 | 0.210 |
Why?
|
| Disease Models, Animal | 7 | 2021 | 2281 | 0.200 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2010 | 128 | 0.190 |
Why?
|
| Immunoglobulin G | 2 | 2015 | 464 | 0.190 |
Why?
|
| Fibroblasts | 2 | 2016 | 421 | 0.190 |
Why?
|
| Epithelial Cells | 2 | 2024 | 410 | 0.190 |
Why?
|
| Hepatitis | 1 | 2023 | 58 | 0.190 |
Why?
|
| Islets of Langerhans | 2 | 2018 | 286 | 0.190 |
Why?
|
| Intestinal Mucosa | 1 | 2024 | 249 | 0.190 |
Why?
|
| Toll-Like Receptor 9 | 6 | 2013 | 207 | 0.180 |
Why?
|
| Cell Line | 13 | 2010 | 2021 | 0.180 |
Why?
|
| Models, Biological | 4 | 2016 | 1192 | 0.180 |
Why?
|
| Schiff Bases | 1 | 2001 | 1 | 0.180 |
Why?
|
| Semicarbazides | 1 | 2001 | 2 | 0.180 |
Why?
|
| Hepatitis, Alcoholic | 1 | 2023 | 78 | 0.180 |
Why?
|
| Ventricular Remodeling | 2 | 2020 | 89 | 0.180 |
Why?
|
| Influenza A virus | 1 | 2023 | 119 | 0.180 |
Why?
|
| T-Lymphocytes | 5 | 2014 | 1005 | 0.170 |
Why?
|
| Lysosomes | 5 | 2014 | 167 | 0.170 |
Why?
|
| Endosomes | 3 | 2014 | 180 | 0.170 |
Why?
|
| Th1 Cells | 3 | 2015 | 171 | 0.170 |
Why?
|
| Interferon-gamma | 6 | 2020 | 574 | 0.170 |
Why?
|
| Cholesterol | 2 | 2014 | 261 | 0.170 |
Why?
|
| Proteolysis | 2 | 2019 | 154 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2023 | 440 | 0.160 |
Why?
|
| Th2 Cells | 2 | 2015 | 93 | 0.160 |
Why?
|
| Myocardium | 2 | 2020 | 301 | 0.160 |
Why?
|
| Malaria, Cerebral | 1 | 2020 | 23 | 0.160 |
Why?
|
| Complement C3 | 2 | 2020 | 60 | 0.160 |
Why?
|
| Interferon Regulatory Factor-3 | 4 | 2014 | 98 | 0.160 |
Why?
|
| Influenza, Human | 1 | 2023 | 203 | 0.160 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2011 | 149 | 0.160 |
Why?
|
| Angiotensin II | 1 | 2020 | 25 | 0.160 |
Why?
|
| Acyltransferases | 3 | 2009 | 32 | 0.160 |
Why?
|
| Inflammation Mediators | 3 | 2010 | 179 | 0.150 |
Why?
|
| Macrophage Activation | 5 | 2018 | 115 | 0.150 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 92 | 0.150 |
Why?
|
| Streptolysins | 1 | 2019 | 9 | 0.150 |
Why?
|
| Streptococcus pyogenes | 1 | 2019 | 29 | 0.150 |
Why?
|
| Type III Secretion Systems | 1 | 2018 | 3 | 0.140 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2020 | 92 | 0.140 |
Why?
|
| Immunity | 1 | 2019 | 107 | 0.140 |
Why?
|
| Streptococcal Infections | 1 | 2019 | 84 | 0.140 |
Why?
|
| Multiple Sclerosis | 1 | 2021 | 226 | 0.140 |
Why?
|
| Endocytosis | 3 | 2014 | 152 | 0.140 |
Why?
|
| CARD Signaling Adaptor Proteins | 5 | 2023 | 66 | 0.140 |
Why?
|
| Sepsis | 1 | 2002 | 293 | 0.140 |
Why?
|
| Monocytes | 6 | 2020 | 361 | 0.130 |
Why?
|
| Pneumonia, Bacterial | 2 | 2016 | 90 | 0.130 |
Why?
|
| Escherichia coli Proteins | 3 | 2009 | 277 | 0.130 |
Why?
|
| Palmitates | 1 | 2016 | 20 | 0.130 |
Why?
|
| Interleukin-6 | 7 | 2020 | 323 | 0.130 |
Why?
|
| Disease | 1 | 2016 | 26 | 0.120 |
Why?
|
| Phagocytosis | 3 | 2010 | 257 | 0.120 |
Why?
|
| Astrocytes | 2 | 2015 | 123 | 0.120 |
Why?
|
| HIV Antibodies | 2 | 2014 | 146 | 0.120 |
Why?
|
| Down-Regulation | 2 | 2010 | 324 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2018 | 319 | 0.120 |
Why?
|
| Klebsiella Infections | 1 | 2016 | 22 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2001 | 642 | 0.120 |
Why?
|
| Klebsiella pneumoniae | 1 | 2016 | 28 | 0.120 |
Why?
|
| Bacteria | 2 | 2016 | 336 | 0.120 |
Why?
|
| Parvovirus | 2 | 2007 | 25 | 0.120 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2015 | 7 | 0.120 |
Why?
|
| Cellular Senescence | 1 | 2016 | 120 | 0.120 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2015 | 11 | 0.120 |
Why?
|
| Neutrophils | 3 | 2026 | 390 | 0.120 |
Why?
|
| Solubility | 1 | 2015 | 192 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 3 | 2013 | 204 | 0.110 |
Why?
|
| HEK293 Cells | 2 | 2014 | 615 | 0.110 |
Why?
|
| GTP-Binding Proteins | 1 | 2015 | 94 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 211 | 0.110 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2014 | 5 | 0.110 |
Why?
|
| Chemokine CCL4 | 1 | 2014 | 14 | 0.110 |
Why?
|
| Chemokine CCL5 | 1 | 2014 | 32 | 0.110 |
Why?
|
| Viral Envelope Proteins | 1 | 2015 | 101 | 0.110 |
Why?
|
| Mice, Inbred C3H | 5 | 2010 | 173 | 0.110 |
Why?
|
| RNA, Messenger | 7 | 2020 | 1575 | 0.110 |
Why?
|
| Rats | 5 | 2013 | 1989 | 0.110 |
Why?
|
| Aluminum Hydroxide | 1 | 2014 | 3 | 0.110 |
Why?
|
| Phagosomes | 2 | 2014 | 43 | 0.110 |
Why?
|
| Heart | 1 | 2016 | 297 | 0.110 |
Why?
|
| Immunization, Secondary | 1 | 2014 | 52 | 0.100 |
Why?
|
| Hypertension, Pulmonary | 1 | 2015 | 99 | 0.100 |
Why?
|
| RNA, Bacterial | 1 | 2014 | 73 | 0.100 |
Why?
|
| Cell Survival | 1 | 2015 | 587 | 0.100 |
Why?
|
| Hemolysin Proteins | 1 | 2014 | 45 | 0.100 |
Why?
|
| Phospholipids | 1 | 2014 | 81 | 0.100 |
Why?
|
| Immunization | 1 | 2014 | 135 | 0.100 |
Why?
|
| Male | 18 | 2024 | 30953 | 0.100 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2013 | 29 | 0.100 |
Why?
|
| Borrelia | 2 | 2010 | 31 | 0.100 |
Why?
|
| rab GTP-Binding Proteins | 2 | 2010 | 81 | 0.090 |
Why?
|
| Toll-Like Receptor 5 | 2 | 2003 | 11 | 0.090 |
Why?
|
| Intestines | 1 | 2013 | 178 | 0.090 |
Why?
|
| Ligands | 2 | 2004 | 415 | 0.090 |
Why?
|
| Immunologic Memory | 1 | 2014 | 281 | 0.090 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 151 | 0.090 |
Why?
|
| HIV-1 | 2 | 2014 | 706 | 0.090 |
Why?
|
| Neisseria gonorrhoeae | 2 | 2005 | 204 | 0.090 |
Why?
|
| Interleukin-12 Subunit p40 | 2 | 2008 | 18 | 0.090 |
Why?
|
| Lung | 3 | 2015 | 962 | 0.090 |
Why?
|
| Mice, Inbred Strains | 2 | 2013 | 185 | 0.090 |
Why?
|
| Heart Ventricles | 1 | 2013 | 266 | 0.090 |
Why?
|
| Brain | 2 | 2020 | 1601 | 0.090 |
Why?
|
| RNA Stability | 1 | 2011 | 104 | 0.080 |
Why?
|
| Flow Cytometry | 4 | 2010 | 662 | 0.080 |
Why?
|
| Obesity | 1 | 2019 | 1266 | 0.080 |
Why?
|
| Shock, Septic | 2 | 2010 | 89 | 0.080 |
Why?
|
| Toxoplasmosis, Animal | 1 | 2010 | 10 | 0.080 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2010 | 12 | 0.080 |
Why?
|
| CpG Islands | 3 | 2010 | 219 | 0.080 |
Why?
|
| Relapsing Fever | 1 | 2010 | 16 | 0.080 |
Why?
|
| Ki-67 Antigen | 1 | 2010 | 37 | 0.080 |
Why?
|
| Tamoxifen | 1 | 2010 | 42 | 0.080 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2010 | 38 | 0.080 |
Why?
|
| Lymphocyte Activation | 2 | 2010 | 752 | 0.080 |
Why?
|
| Antibody Formation | 1 | 2010 | 110 | 0.080 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2010 | 22 | 0.080 |
Why?
|
| Antibodies, Bacterial | 2 | 2010 | 181 | 0.080 |
Why?
|
| Acute Lung Injury | 1 | 2010 | 45 | 0.080 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 129 | 0.080 |
Why?
|
| Female | 16 | 2024 | 33927 | 0.080 |
Why?
|
| Membrane Transport Proteins | 1 | 2010 | 135 | 0.080 |
Why?
|
| Chlamydia Infections | 1 | 2010 | 79 | 0.080 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2009 | 17 | 0.070 |
Why?
|
| Cell Membrane | 4 | 2008 | 505 | 0.070 |
Why?
|
| Enzyme Activation | 3 | 2020 | 391 | 0.070 |
Why?
|
| Boutonneuse Fever | 1 | 2008 | 1 | 0.070 |
Why?
|
| Rickettsia Infections | 1 | 2008 | 1 | 0.070 |
Why?
|
| Insect Bites and Stings | 1 | 2008 | 2 | 0.070 |
Why?
|
| Rats, Inbred BB | 1 | 2009 | 134 | 0.070 |
Why?
|
| Diet, High-Fat | 2 | 2020 | 180 | 0.070 |
Why?
|
| Bacterial Vaccines | 1 | 2009 | 79 | 0.070 |
Why?
|
| In Vitro Techniques | 4 | 2020 | 491 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 555 | 0.070 |
Why?
|
| Teichoic Acids | 1 | 2008 | 12 | 0.070 |
Why?
|
| Liver | 3 | 2020 | 868 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2010 | 160 | 0.070 |
Why?
|
| Chemokines | 1 | 2008 | 92 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 1 | 2008 | 95 | 0.070 |
Why?
|
| CD36 Antigens | 1 | 2008 | 26 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 4 | 2014 | 869 | 0.070 |
Why?
|
| Trypanosoma cruzi | 1 | 2008 | 53 | 0.070 |
Why?
|
| Mice, Inbred NOD | 1 | 2009 | 526 | 0.070 |
Why?
|
| HIV Infections | 2 | 2004 | 955 | 0.070 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2008 | 146 | 0.070 |
Why?
|
| B-Lymphocytes | 2 | 2007 | 563 | 0.060 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2007 | 34 | 0.060 |
Why?
|
| CHO Cells | 3 | 2002 | 192 | 0.060 |
Why?
|
| Immunoglobulin M | 1 | 2007 | 116 | 0.060 |
Why?
|
| Health | 1 | 2007 | 30 | 0.060 |
Why?
|
| Spleen | 3 | 2020 | 474 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 2 | 2008 | 176 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2008 | 242 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2009 | 219 | 0.060 |
Why?
|
| Rhinovirus | 1 | 2006 | 4 | 0.060 |
Why?
|
| Poly I-C | 3 | 2013 | 76 | 0.060 |
Why?
|
| Cricetinae | 3 | 2002 | 362 | 0.060 |
Why?
|
| Cell Movement | 1 | 2008 | 480 | 0.060 |
Why?
|
| Antigens, Bacterial | 1 | 2007 | 200 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 918 | 0.060 |
Why?
|
| Complement C4b-Binding Protein | 1 | 2005 | 30 | 0.060 |
Why?
|
| Golgi Apparatus | 2 | 2003 | 65 | 0.060 |
Why?
|
| Interleukin-1 | 4 | 2010 | 154 | 0.060 |
Why?
|
| Interleukin-8 | 2 | 2003 | 95 | 0.060 |
Why?
|
| Fibrosis | 2 | 2020 | 172 | 0.060 |
Why?
|
| Parvoviridae Infections | 1 | 2005 | 23 | 0.050 |
Why?
|
| Antigens, Surface | 2 | 2002 | 199 | 0.050 |
Why?
|
| Interleukin-10 | 3 | 2015 | 164 | 0.050 |
Why?
|
| Cell Wall | 2 | 2003 | 117 | 0.050 |
Why?
|
| Bacteroidaceae Infections | 1 | 2004 | 3 | 0.050 |
Why?
|
| Porphyromonas gingivalis | 1 | 2004 | 17 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 32 | 0.050 |
Why?
|
| Dimerization | 3 | 2009 | 145 | 0.050 |
Why?
|
| Periodontitis | 1 | 2004 | 15 | 0.050 |
Why?
|
| Neurodegenerative Diseases | 1 | 2006 | 151 | 0.050 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family | 1 | 2023 | 6 | 0.050 |
Why?
|
| Colitis | 1 | 2024 | 77 | 0.050 |
Why?
|
| Organ Size | 2 | 2020 | 173 | 0.050 |
Why?
|
| Vaccination | 1 | 2006 | 375 | 0.050 |
Why?
|
| Gonorrhea | 1 | 2005 | 162 | 0.050 |
Why?
|
| Neutrophil Activation | 1 | 2023 | 23 | 0.050 |
Why?
|
| Transfection | 5 | 2003 | 701 | 0.050 |
Why?
|
| Regeneration | 1 | 2024 | 125 | 0.050 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2003 | 23 | 0.050 |
Why?
|
| Burns | 1 | 2003 | 45 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2002 | 856 | 0.050 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2024 | 110 | 0.050 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 1224 | 0.050 |
Why?
|
| Measles virus | 1 | 2002 | 2 | 0.050 |
Why?
|
| Hemagglutinins, Viral | 1 | 2002 | 11 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 449 | 0.050 |
Why?
|
| Hexuronic Acids | 1 | 2002 | 23 | 0.050 |
Why?
|
| Escherichia coli | 4 | 2010 | 713 | 0.050 |
Why?
|
| Gene Expression | 2 | 2016 | 852 | 0.050 |
Why?
|
| Immune System | 1 | 2003 | 132 | 0.050 |
Why?
|
| Cushing Syndrome | 1 | 2002 | 10 | 0.050 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2002 | 58 | 0.040 |
Why?
|
| Disease Susceptibility | 2 | 2016 | 168 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2002 | 202 | 0.040 |
Why?
|
| Cervix Uteri | 1 | 2002 | 58 | 0.040 |
Why?
|
| Growth Inhibitors | 1 | 2001 | 24 | 0.040 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2002 | 49 | 0.040 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2001 | 52 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2001 | 44 | 0.040 |
Why?
|
| Vagina | 1 | 2002 | 87 | 0.040 |
Why?
|
| Biopolymers | 1 | 2002 | 72 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2001 | 111 | 0.040 |
Why?
|
| Protein Binding | 3 | 2015 | 1639 | 0.040 |
Why?
|
| Mammals | 1 | 2003 | 222 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 1217 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2002 | 237 | 0.040 |
Why?
|
| Biomarkers | 3 | 2020 | 1476 | 0.040 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2002 | 81 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 198 | 0.040 |
Why?
|
| Microscopy, Confocal | 3 | 2010 | 240 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 426 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2002 | 152 | 0.040 |
Why?
|
| Disease Progression | 2 | 2021 | 1214 | 0.040 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2020 | 12 | 0.040 |
Why?
|
| Benzoquinones | 1 | 2020 | 14 | 0.040 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2020 | 19 | 0.040 |
Why?
|
| Plasmodium chabaudi | 1 | 2020 | 30 | 0.040 |
Why?
|
| Lactams, Macrocyclic | 1 | 2020 | 31 | 0.040 |
Why?
|
| Cell Division | 1 | 2001 | 449 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2020 | 29 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2002 | 292 | 0.040 |
Why?
|
| Cardiomegaly | 1 | 2020 | 37 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 875 | 0.040 |
Why?
|
| Systole | 1 | 2020 | 109 | 0.040 |
Why?
|
| Ethanol | 1 | 2023 | 329 | 0.040 |
Why?
|
| Peptides | 1 | 2023 | 588 | 0.040 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2020 | 63 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 148 | 0.040 |
Why?
|
| Drosophila | 1 | 2003 | 480 | 0.040 |
Why?
|
| Myocytes, Cardiac | 1 | 2020 | 121 | 0.040 |
Why?
|
| Neisseria meningitidis | 1 | 2000 | 76 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2020 | 222 | 0.040 |
Why?
|
| Luminescent Proteins | 3 | 2004 | 129 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2019 | 117 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 285 | 0.030 |
Why?
|
| src-Family Kinases | 2 | 2010 | 64 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2002 | 322 | 0.030 |
Why?
|
| Middle Aged | 6 | 2020 | 18208 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 239 | 0.030 |
Why?
|
| Time Factors | 3 | 2013 | 3758 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2020 | 525 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2004 | 500 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2002 | 559 | 0.030 |
Why?
|
| Chemokine CXCL2 | 1 | 2016 | 16 | 0.030 |
Why?
|
| Insulin-Secreting Cells | 1 | 2018 | 195 | 0.030 |
Why?
|
| Cell Separation | 2 | 2010 | 147 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 542 | 0.030 |
Why?
|
| Panax | 1 | 1996 | 3 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 2 | 2011 | 235 | 0.030 |
Why?
|
| Plants, Medicinal | 1 | 1996 | 19 | 0.030 |
Why?
|
| Vaccines, Attenuated | 2 | 2009 | 35 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 2016 | 84 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 301 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2016 | 80 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2009 | 710 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2019 | 414 | 0.030 |
Why?
|
| Base Sequence | 2 | 2011 | 1329 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2011 | 1979 | 0.030 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2015 | 7 | 0.030 |
Why?
|
| Insulin | 1 | 2019 | 695 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2015 | 42 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2015 | 49 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2015 | 239 | 0.030 |
Why?
|
| Toll-Like Receptor 1 | 2 | 2007 | 22 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2009 | 676 | 0.030 |
Why?
|
| Immune Evasion | 1 | 2015 | 71 | 0.030 |
Why?
|
| Leukocytes | 1 | 2015 | 105 | 0.030 |
Why?
|
| Polysaccharides | 1 | 1996 | 153 | 0.030 |
Why?
|
| Arteries | 1 | 2015 | 81 | 0.030 |
Why?
|
| Collagen | 1 | 2015 | 135 | 0.030 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2004 | 94 | 0.030 |
Why?
|
| Species Specificity | 2 | 2005 | 339 | 0.030 |
Why?
|
| Vaccines, Subunit | 1 | 2014 | 40 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2008 | 247 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2014 | 166 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 380 | 0.020 |
Why?
|
| Adult | 4 | 2020 | 17313 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 895 | 0.020 |
Why?
|
| Rabbits | 1 | 2014 | 338 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2013 | 88 | 0.020 |
Why?
|
| Potassium | 1 | 2013 | 97 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2013 | 182 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2005 | 610 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 217 | 0.020 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2011 | 9 | 0.020 |
Why?
|
| Half-Life | 1 | 2011 | 81 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2011 | 95 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2013 | 299 | 0.020 |
Why?
|
| CD18 Antigens | 2 | 2002 | 30 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 2 | 2003 | 372 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2013 | 278 | 0.020 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2010 | 26 | 0.020 |
Why?
|
| Diet, Atherogenic | 1 | 2010 | 7 | 0.020 |
Why?
|
| Peritoneal Cavity | 1 | 2010 | 30 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2010 | 75 | 0.020 |
Why?
|
| Cathepsin L | 1 | 2010 | 21 | 0.020 |
Why?
|
| Cathepsin B | 1 | 2010 | 14 | 0.020 |
Why?
|
| Toxoplasma | 1 | 2010 | 34 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 2010 | 35 | 0.020 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2010 | 7 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 202 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2010 | 40 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2010 | 44 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 233 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2010 | 127 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2010 | 109 | 0.020 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2010 | 29 | 0.020 |
Why?
|
| Phagocytes | 1 | 2010 | 51 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2010 | 91 | 0.020 |
Why?
|
| Crystallization | 1 | 2010 | 98 | 0.020 |
Why?
|
| Interferon Regulatory Factors | 1 | 2010 | 43 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2010 | 193 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2010 | 140 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 4793 | 0.020 |
Why?
|
| Macrophages, Alveolar | 1 | 2010 | 65 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 2010 | 178 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2010 | 127 | 0.020 |
Why?
|
| Leukosialin | 1 | 2009 | 2 | 0.020 |
Why?
|
| Administration, Intranasal | 1 | 2009 | 27 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2010 | 99 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 286 | 0.020 |
Why?
|
| Bacteremia | 1 | 2010 | 91 | 0.020 |
Why?
|
| Hyaluronan Receptors | 1 | 2009 | 35 | 0.020 |
Why?
|
| Hyaluronic Acid | 1 | 2010 | 70 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2009 | 58 | 0.020 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2009 | 5 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2010 | 180 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 414 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 251 | 0.020 |
Why?
|
| Rickettsieae | 1 | 2008 | 1 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2009 | 46 | 0.020 |
Why?
|
| Neoplasms | 1 | 2019 | 1365 | 0.020 |
Why?
|
| Siphonaptera | 1 | 2008 | 1 | 0.020 |
Why?
|
| Chemokine CCL19 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Insect Vectors | 1 | 2008 | 15 | 0.020 |
Why?
|
| Ticks | 1 | 2008 | 35 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2010 | 739 | 0.020 |
Why?
|
| Dynamin I | 1 | 2008 | 1 | 0.020 |
Why?
|
| Acetylation | 1 | 2008 | 121 | 0.020 |
Why?
|
| trans-Golgi Network | 1 | 2008 | 8 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 739 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 2008 | 34 | 0.020 |
Why?
|
| Retroelements | 1 | 2008 | 44 | 0.020 |
Why?
|
| Host-Parasite Interactions | 1 | 2008 | 61 | 0.020 |
Why?
|
| Opsonin Proteins | 1 | 2008 | 32 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 372 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2008 | 144 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2009 | 576 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2009 | 241 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 14924 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 1108 | 0.020 |
Why?
|
| Biological Transport | 1 | 2008 | 292 | 0.020 |
Why?
|
| Borrelia Infections | 1 | 2007 | 12 | 0.020 |
Why?
|
| Lipids | 1 | 2009 | 327 | 0.020 |
Why?
|
| Breeding | 1 | 2007 | 29 | 0.020 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2007 | 59 | 0.020 |
Why?
|
| Dogs | 1 | 2008 | 315 | 0.020 |
Why?
|
| Chloroquine | 1 | 2007 | 56 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 521 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 643 | 0.020 |
Why?
|
| STAT1 Transcription Factor | 1 | 2006 | 35 | 0.020 |
Why?
|
| Oligodendroglia | 1 | 2006 | 37 | 0.020 |
Why?
|
| Pan troglodytes | 1 | 2005 | 33 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2007 | 231 | 0.010 |
Why?
|
| Genome, Viral | 1 | 2007 | 144 | 0.010 |
Why?
|
| Blood Bactericidal Activity | 1 | 2005 | 61 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 1775 | 0.010 |
Why?
|
| Porins | 1 | 2005 | 63 | 0.010 |
Why?
|
| Parvoviridae | 1 | 2005 | 5 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 793 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 2004 | 16 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2005 | 300 | 0.010 |
Why?
|
| Vaccinia | 1 | 2005 | 29 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2006 | 541 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 2482 | 0.010 |
Why?
|
| Oxidoreductases | 1 | 2005 | 58 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 622 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2005 | 260 | 0.010 |
Why?
|
| Interleukins | 1 | 2005 | 86 | 0.010 |
Why?
|
| Vaccinia virus | 1 | 2005 | 69 | 0.010 |
Why?
|
| Fimbriae, Bacterial | 1 | 2004 | 20 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2004 | 92 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2004 | 129 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2004 | 38 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 2004 | 115 | 0.010 |
Why?
|
| Allergens | 1 | 2003 | 54 | 0.010 |
Why?
|
| Antigens, Ly | 1 | 2003 | 44 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2003 | 287 | 0.010 |
Why?
|
| Chimera | 1 | 2003 | 44 | 0.010 |
Why?
|
| Brefeldin A | 1 | 2002 | 7 | 0.010 |
Why?
|
| Membrane Cofactor Protein | 1 | 2002 | 1 | 0.010 |
Why?
|
| Measles Vaccine | 1 | 2002 | 2 | 0.010 |
Why?
|
| CD11b Antigen | 1 | 2002 | 19 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2002 | 32 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 77 | 0.010 |
Why?
|
| Drug Design | 1 | 2003 | 137 | 0.010 |
Why?
|
| Virus Replication | 1 | 2004 | 323 | 0.010 |
Why?
|
| Culture Media | 1 | 2003 | 78 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 1 | 2002 | 66 | 0.010 |
Why?
|
| Luciferases | 1 | 2002 | 107 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 1589 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 97 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 257 | 0.010 |
Why?
|
| Immunity, Mucosal | 1 | 2002 | 53 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 237 | 0.010 |
Why?
|
| Kinetics | 1 | 2003 | 759 | 0.010 |
Why?
|
| Hormones | 1 | 2002 | 62 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2002 | 130 | 0.010 |
Why?
|
| Plasmids | 1 | 2002 | 294 | 0.010 |
Why?
|
| Bone Density | 1 | 2002 | 142 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2002 | 342 | 0.010 |
Why?
|
| Protein Transport | 1 | 2002 | 404 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2004 | 1138 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 401 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 201 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2007 | 918 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2004 | 1280 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2002 | 192 | 0.010 |
Why?
|
| Neurons | 1 | 2006 | 933 | 0.010 |
Why?
|
| Kidney | 1 | 2003 | 450 | 0.010 |
Why?
|
| CD11 Antigens | 1 | 1999 | 16 | 0.010 |
Why?
|
| Endotoxins | 1 | 1999 | 81 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2004 | 2702 | 0.010 |
Why?
|
| Complement Inactivator Proteins | 1 | 1996 | 8 | 0.010 |
Why?
|
| Interferon Type I | 1 | 1996 | 196 | 0.010 |
Why?
|
| Mutation | 1 | 2000 | 2657 | 0.010 |
Why?
|